Luciano Nicosia

Luciano Nicosia

Auto-generated profile, based on publicly available information

Luciano Nicosia

Leukaemia Biology Laboratory, Cancer Research UK Manchester Institute, The University of Manchester, Manchester Cancer Research Centre Building, Manchester, UK

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 April 2020 in Science Advances
Verified
Journal Article
Open access
PDF file
RRRoberto Ravasio
Roberto Ravasio
ECElena Ceccacci
Elena Ceccacci
LNLuciano Nicosia
Luciano Nicosia
AHAmir Hosseini
Amir Hosseini
PRPier Luigi Rossi
Pier Luigi Rossi
SMSaverio Minucci
Saverio Minucci
The study addresses the mechanism through which inhibition of LSD1 sensitizes AML cells to retinoic acid–induced differentiation.

8 December 2021 in Science Translational Medicine
Verified
Journal Article
Closed access
SFStefania Faletti
Stefania Faletti
DODaniela Osti
Daniela Osti
ECElena Ceccacci
Elena Ceccacci
CRCristina Richichi
Cristina Richichi
BCBrunella Costanza
Brunella Costanza
GPGiuliana Pelicci
Giuliana Pelicci
Inhibiting LSD1 reduces glioblastoma tumor-initiating cell survival by impeding their ability to handle the stress through the deregulation of ATF4.

3 December 2021 in Oncogene
Verified
Journal Article
Open access
PDF file
LNLuciano Nicosia
Luciano Nicosia
FBFrancesca Ludovica Boffo
Francesca Ludovica Boffo
ECElena Ceccacci
Elena Ceccacci
FCFabio Conforti
Fabio Conforti
IPIsabella Pallavicini
Isabella Pallavicini
Tiziana BonaldiTiziana Bonaldi
Tiziana Bonaldi
The histone demethylase LSD1 is over-expressed in hematological tumors and has emerged as a promising target for anticancer treatment, so that several LSD1 inhibitors are under development and testing, in preclinical and clinical settings. However, the complete understanding of their complex mechanism of action is still unreached. Here, we unraveled a novel mode of action of the LSD1 inhibitors MC2580 and DDP-38003, showing that they can induce differentiation of AML cells through the downregulation of the chromatin protein GSE1. Analysis of the phenotypic effects of GSE1 depletion in NB4 cells showed a strong decrease of cell viability in vitro and of tumor growth in vivo. Mechanistically, we found that a set of genes associated with immune response and cytokine-signaling pathways are upregulated by LSD1 inhibitors through GSE1-protein reduction and that LSD1 and GSE1 colocalize at promoters of a subset of these genes at the basal state, enforcing their transcriptional silencing. Moreover, we show that LSD1 inhibitors lead to the reduced binding of GSE1 to these promoters, activating transcriptional programs that trigger myeloid differentiation. Our study offers new insights into GSE1 as a novel therapeutic target for AML.

28 September 2022 in Oncogene
Verified
Journal Article
Open access
PDF file
AMAlba Maiques-Diaz
Alba Maiques-Diaz
LNLuciano Nicosia
Luciano Nicosia
NBNaseer J. Basma
Naseer J. Basma
IRIsabel Romero-Camarero
Isabel Romero-Camarero
FCFrancesco Camera
Francesco Camera
TSTim Somervaille
Tim Somervaille
Pharmacologic inhibition of LSD1 induces molecular and morphologic differentiation of blast cells in acute myeloid leukemia (AML) patients harboring MLL gene translocations. In addition to its demethylase activity, LSD1 has a critical scaffolding function at genomic sites occupied by the SNAG domain transcription repressor GFI1. Importantly, inhibitors block both enzymatic and scaffolding activities, in the latter case by disrupting the protein:protein interaction of GFI1 with LSD1. To explore the wider consequences of LSD1 inhibition on the LSD1 protein complex we applied mass spectrometry technologies. We discovered that the interaction of the HMG-box protein HMG20B with LSD1 was also disrupted by LSD1 inhibition. Downstream investigations revealed that HMG20B is co-located on chromatin with GFI1 and LSD1 genome-wide; the strongest HMG20B binding co-locates with the strongest GFI1 and LSD1 binding. Functional assays demonstrated that HMG20B depletion induces leukemia cell differentiation and further revealed that HMG20B is required for the transcription repressor activity of GFI1 through stabilizing LSD1 on chromatin at GFI1 binding sites. Interaction of HMG20B with LSD1 is through its coiled-coil domain. Thus, HMG20B is a critical component of the GFI1:LSD1 transcription repressor complex which contributes to leukemia cell differentiation block.

16 February 2021 in bioRxiv
Verified
Preprint
Open access
PDF file
LNLuciano Nicosia
Luciano Nicosia
FBFrancesca Ludovica Boffo
Francesca Ludovica Boffo
ECElena Ceccacci
Elena Ceccacci
IPIsabella Pallavicini
Isabella Pallavicini
FBFabio Bedin
Fabio Bedin
Tiziana BonaldiTiziana Bonaldi
Tiziana Bonaldi
The histone de-methylase LSD1 is over-expressed in haematological tumours and has emerged as a promising target for anti-cancer treatment, so that several LSD1 inhibitors are under development and testing, in pre-clinical and clinical settings. However, the complete understanding of their complex mechanism of action is still unreached. Here, we unravelled a novel mode of action of the LSD1 inhibitors MC2580 and DDP-38003, showing that they can induce differentiation of AML cells through the down-regulation of the chromatin protein GSE1. Analysis of the phenotypic effects of GSE1 depletion in NB4 cells showed a strong decrease of cell viability in vitro and of tumour growth in vivo . Mechanistically, we found that a set of genes associated with immune response and cytokine signalling pathways are up-regulated by LSD1 inhibitors through GSE1 protein reduction and that LSD1 and GSE1 co-localise at promoters of a subset of these genes at the basal state, enforcing their transcriptional silencing. Moreover, we show that LSD1 inhibitors lead to the reduced binding of GSE1 to these promoters, activating transcriptional programs that trigger myeloid differentiation. Our study offers new insights on GSE1 as a novel therapeutic target for AML.